Terms: = Ovarian cancer AND LEF1, TCF1ALPHA, 51176, ENSG00000138795, Q9UJU2, DKFZp586H0919
12 results:
1. Loss of CBX2 causes genomic instability and Wnt activation in high grade serous ovarian carcinoma cells.
Ma Y; Liu L; Wei Z; Zhu M; Huang L; Wang S; Yi X; Ying F; Zhao S; Cai J; Wang Z; Sun S
Mol Carcinog; 2023 Apr; 62(4):479-492. PubMed ID: 36621979
[TBL] [Abstract] [Full Text] [Related]
2. Clinicopathological features and prognostic significance of CTNNB1 mutation in low-grade, early-stage endometrial endometrioid carcinoma.
Ruz-Caracuel I; López-Janeiro Á; Heredia-Soto V; Ramón-Patino JL; Yébenes L; Berjón A; Hernández A; Gallego A; Ruiz P; Redondo A; Peláez-García A; Mendiola M; Hardisson D
Virchows Arch; 2021 Dec; 479(6):1167-1176. PubMed ID: 34420090
[TBL] [Abstract] [Full Text] [Related]
3. Knockdown of Tripartite Motif Containing 28 suppresses the migration, invasion and epithelial-mesenchymal transition in ovarian carcinoma cells through down-regulation of Wnt/β-catenin signaling pathway.
Deng B; Zhang S; Zhang Y; Miao Y; Meng X; Guo K
Neoplasma; 2017; 64(6):893-900. PubMed ID: 28895414
[TBL] [Abstract] [Full Text] [Related]
4. lef1 is preferentially expressed in the tubal-peritoneal junctions and is a reliable marker of tubal intraepithelial lesions.
Schmoeckel E; Odai-Afotey AA; Schleißheimer M; Rottmann M; Flesken-Nikitin A; Ellenson LH; Kirchner T; Mayr D; Nikitin AY
Mod Pathol; 2017 Sep; 30(9):1241-1250. PubMed ID: 28664938
[TBL] [Abstract] [Full Text] [Related]
5. Gene expression profiling analysis of the role of miR-22 in clear cell ovarian cancer.
Zhen YB; Guo XL; Xu B; Zhao HW; Xu CJ
Neoplasma; 2016; 63(6):856-864. PubMed ID: 27565323
[TBL] [Abstract] [Full Text] [Related]
6. VAV3 Overexpressed in cancer Stem Cells Is a Poor Prognostic Indicator in ovarian cancer Patients.
Kwon AY; Kim GI; Jeong JY; Song JY; Kwack KB; Lee C; Kang HY; Kim TH; Heo JH; An HJ
Stem Cells Dev; 2015 Jul; 24(13):1521-35. PubMed ID: 25715123
[TBL] [Abstract] [Full Text] [Related]
7. Through the glass darkly: intraepithelial neoplasia, top-down differentiation, and the road to ovarian cancer.
Crum CP; Herfs M; Ning G; Bijron JG; Howitt BE; Jimenez CA; Hanamornroongruang S; McKeon FD; Xian W
J Pathol; 2013 Dec; 231(4):402-12. PubMed ID: 24030860
[TBL] [Abstract] [Full Text] [Related]
8. Fucosyltransferase 8 as a functional regulator of nonsmall cell lung cancer.
Chen CY; Jan YH; Juan YH; Yang CJ; Huang MS; Yu CJ; Yang PC; Hsiao M; Hsu TL; Wong CH
Proc Natl Acad Sci U S A; 2013 Jan; 110(2):630-5. PubMed ID: 23267084
[TBL] [Abstract] [Full Text] [Related]
9. An integrative ChIP-chip and gene expression profiling to model SMAD regulatory modules.
Qin H; Chan MW; Liyanarachchi S; Balch C; Potter D; Souriraj IJ; Cheng AS; Agosto-Perez FJ; Nikonova EV; Yan PS; Lin HJ; Nephew KP; Saltz JH; Showe LC; Huang TH; Davuluri RV
BMC Syst Biol; 2009 Jul; 3():73. PubMed ID: 19615063
[TBL] [Abstract] [Full Text] [Related]
10. The morphogenic function of E-cadherin-mediated adherens junctions in epithelial ovarian carcinoma formation and progression.
Wu C; Cipollone J; Maines-Bandiera S; Tan C; Karsan A; Auersperg N; Roskelley CD
Differentiation; 2008 Feb; 76(2):193-205. PubMed ID: 17608733
[TBL] [Abstract] [Full Text] [Related]
11. Wnt-signalling pathway in ovarian epithelial tumours: increased expression of beta-catenin and GSK3beta.
Rask K; Nilsson A; Brännström M; Carlsson P; Hellberg P; Janson PO; Hedin L; Sundfeldt K
Br J Cancer; 2003 Oct; 89(7):1298-304. PubMed ID: 14520463
[TBL] [Abstract] [Full Text] [Related]
12. Mutations of the beta- and gamma-catenin genes are uncommon in human lung, breast, kidney, cervical and ovarian carcinomas.
Ueda M; Gemmill RM; West J; Winn R; Sugita M; Tanaka N; Ueki M; Drabkin HA
Br J Cancer; 2001 Jul; 85(1):64-8. PubMed ID: 11437403
[TBL] [Abstract] [Full Text] [Related]
